secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001824293-24-000060
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio announces 1-for-13 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------

- Reverse split at 1-for-13 effective 4:01 p.m. ET June 17, 2024; split-adjusted trading starts June 18, 2024.
- Approximately 6.6M pre-split shares reduce to about 508K post-split shares; no change to authorized shares.
- Purpose is to boost per-share price to satisfy Nasdaq minimum bid price requirement for continued listing.
- No fractional shares issued; cash in lieu based on June 17 closing price; CUSIP changes to 3622AW 304.
- Proportional adjustments made to options, warrants, and convertible securities exercise prices and share counts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000060/0001824293-24-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000060/val-20240613.htm
  HTML page:      https://secwatch.observer/filing/0001824293-24-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer